Nearly two years after a momentous ruling from the U.S. Supreme Court that led to half of all states banning or restricting abortion access, the top court will hear arguments on Tuesday in a case that could have significant consequences for the availability of the abortion medication mifepristone.
Mifepristone, along with misoprostol, is one of two pills used in the most common type of abortion in the nation.
The arguments, and the resulting opinion, will be watched closely after a 2022 decision in Dobbs v. Jackson Women’s Health Organization, which enabled 14 states to completely ban medical abortions.
The development made the U.S. an
This story was originally published on CBC News. To read the rest of this news worthy story, please visit https://www.cbc.ca/news/world/supreme-court-medication-1.7154354?cmp=rss.